Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-22 3:24 pm Purchase | 2024-09-30 | 13G | RECURSION PHARMACEUTICALS INC RXRX | BlackRock, Inc. BLK | 20,742,797 7.500% | 8,348,925 (+67.36%) | Filing History |
| 2024-10-18 10:59 am Purchase | 2024-09-30 | 13G | RECURSION PHARMACEUTICALS INC RXRX | STATE STREET CORPORATION STT | 12,870,272 4.700% | 718,626 (+5.91%) | Filing History |
| 2024-07-08 4:17 pm Purchase | 2024-06-28 | 13G | RECURSION PHARMACEUTICALS INC RXRX | RA CAPITAL MANAGEMENT L.P. | 15,384,615 5.900% | 15,384,615 (New Position) | Filing History |
| 2024-02-13 5:12 pm Purchase | 2023-12-29 | 13G | RECURSION PHARMACEUTICALS INC RXRX | VANGUARD GROUP INC | 15,665,210 7.520% | 5,607,847 (+55.76%) | Filing History |
| 2024-02-12 12:21 pm Purchase | 2024-01-31 | 13G | RECURSION PHARMACEUTICALS INC RXRX | ARK Investment Management LLC | 23,076,052 11.080% | 2,421,765 (+11.73%) | Filing History |
| 2024-02-09 09:49 am Purchase | 2024-02-08 | 13G | RECURSION PHARMACEUTICALS INC RXRX | FMR LLC | 10,897,286 5.231% | 10,897,286 (New Position) | Filing History |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | RECURSION PHARMACEUTICALS INC RXRX | BlackRock, Inc. BLK | 12,393,872 6.000% | 1,726,248 (+16.18%) | Filing History |
| 2024-01-29 4:00 pm Purchase | 2023-12-31 | 13G | RECURSION PHARMACEUTICALS INC RXRX | ARK Investment Management LLC | 20,654,287 9.920% | 20,654,287 (New Position) | Filing History |
| 2024-01-26 10:49 am Sale | 2023-12-29 | 13G | RECURSION PHARMACEUTICALS INC RXRX | BAILLIE GIFFORD & CO | 24,179,504 11.610% | -641,346 (-2.58%) | Filing History |
| 2024-01-24 10:13 am Purchase | 2023-12-31 | 13G | RECURSION PHARMACEUTICALS INC RXRX | STATE STREET CORPORATION STT | 12,151,646 5.830% | 12,151,646 (New Position) | Filing History |
| 2023-05-22 4:05 pm Purchase | 2023-05-12 | 13G | RECURSION PHARMACEUTICALS INC RXRX | KINNEVIK AB (PUBL) | 10,405,668 5.600% | 10,405,668 (New Position) | Filing History |
| 2023-02-14 4:05 pm Sale | 2022-12-31 | 13G | RECURSION PHARMACEUTICALS INC RXRX | Lux Capital Management LLC | 6,004,722 3.300% | -7,016,797 (-53.89%) | Filing History |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | RECURSION PHARMACEUTICALS INC RXRX | VANGUARD GROUP INC | 10,057,363 5.540% | 10,057,363 (New Position) | Filing History |
| 2023-02-03 12:10 pm Purchase | 2022-12-31 | 13G | RECURSION PHARMACEUTICALS INC RXRX | BlackRock, Inc. BLK | 10,667,624 5.900% | 10,667,624 (New Position) | Filing History |
| 2023-01-24 07:35 am Purchase | 2022-12-30 | 13G | RECURSION PHARMACEUTICALS INC RXRX | BAILLIE GIFFORD & CO | 24,820,850 13.660% | 2,697,695 (+12.19%) | Filing History |
| 2022-10-31 4:08 pm Purchase | 2022-10-27 | 13D | RECURSION PHARMACEUTICALS INC RXRX | Mubadala Investment Co PJSC | 11,291,937 6.300% | 2,551,020 (+29.18%) | Filing History |
| 2022-02-14 4:16 pm Purchase | 2021-12-31 | 13G | RECURSION PHARMACEUTICALS INC RXRX | Lux Capital Management LLC | 13,021,519 8.200% | 13,021,519 (New Position) | Filing History |
| 2022-02-14 3:23 pm Purchase | 2021-12-31 | 13G | RECURSION PHARMACEUTICALS INC RXRX | Data Collective IV, L.P. | 13,619,224 8.500% | 13,619,224 (New Position) | Filing History |
| 2022-01-27 10:18 am Purchase | 2021-12-31 | 13G | RECURSION PHARMACEUTICALS INC RXRX | BAILLIE GIFFORD & CO | 22,123,155 13.870% | 5,104,498 (+29.99%) | Filing History |
| 2021-11-04 5:27 pm Unchanged | 2021-11-01 | 13D | RECURSION PHARMACEUTICALS INC RXRX | Mubadala Investment Co PJSC | 8,740,917 5.500% | 0 (Unchanged) | Filing History |